About WellSpring Pharmaceutical
WellSpring Pharmaceutical is a Healthcare company based in Sarasota (United States) founded in 1999, and was acquired by Avista Capital Partners in August 2022. Prescription and branded OTC drug maker. The company has 137 employees. WellSpring Pharmaceutical has completed 7 acquisitions, including ADskinhealth, Bactine and Bonine. Its focus areas include Traditional Pharmaceuticals, Generics and OTC Drugs. Its legal entity is WellSpring Pharmaceutical Corporation.
Company details
In Oct 2011, Well Spring Pharma was acquired by the PE firms Sentinel Capital Partners and Ancor Capital Partners. Wellspring is a manufacturer and marketer of prescription and branded OTC health and personal care products for the US and Canadian markets. WellSprings products have widespread distribution through pharmaceutical distributors, wholesalers, and major food and drug retailers. The company has a philosophy of developing and marketing niche products including Gelusil, Emetrol and Micatin. WellSpring owns and operates an FDA and Health Canada approved manufacturing plant in Oakville, Ontario, Canada.
- Headquarters Sarasota, United States
- Employees 137
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website wellspringpharm.com
- Social LinkedIn X
- Acquired by Avista Capital Partners (Aug 2022)
- Legal Name Wellspring Pharmaceutical Corporation
- InvestorsAvista Capital Partners
& 1 more
- Employee Count137
- Investments & AcquisitionsADskinhealth
& 6 more
- Acquired by
Investors in WellSpring Pharmaceutical
WellSpring Pharmaceutical has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Avista Capital Partners and Audax Private Equity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments in middle market companies across North America. | audaxprivateequity.com | |||
Private equity investments are focused on the United States market. | avistacap.com | New York, United States |
Investor details for WellSpring Pharmaceutical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of WellSpring Pharmaceutical
26 people are tracked at WellSpring Pharmaceutical (11 in leadership, 15 in team); the tracked headcount is 137.
| Name | Role | Group |
|---|---|---|
David Burgstahler | Managing Partner and Co-CEO | Leadership |
Thania Amberiadis | Vice President | Leadership |
Roshni Charles | Tax Director | Leadership |
Robert Girardi | Partner | Leadership |
John Cafasso | Managing Director & Chief Financial Officer | Leadership |
Amanda Heravi | Managing Director, IR & ESG | Leadership |
Sriram Venkataraman | Partner | Leadership |
Ben Silbert | Managing Director & General Counsel | Leadership |
Thompson Dean | Chairman & Co-Head of Investment Committee | Leadership |
Alex Yu | Partner | Leadership |
Hao Zhao | Vice President | Leadership |
Max Dooley | Assistant Controller | Team |
Neil Ferguson | Strategic Executive | Team |
Anthony Russo | Controller | Team |
Charles Harwood | Operating Executive | Team |
William E. Klitgaard | Operating Advisor | Team |
Ryan Moran | Principal | Team |
Harrison Brenner | Senior Associate | Team |
Hector Cortes | Management Company Controller | Team |
Greg Cowan | Operating Advisor | Team |
6 more people are available in the full profile.
Complete people profiles for WellSpring Pharmaceutical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by WellSpring Pharmaceutical
WellSpring Pharmaceutical has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include ADskinhealth, Bactine and Bonine.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Offers lotions and creams for aging skin relief and maintenance. | dermend.com | Detroit, United States | 1897 | Jan 2026 | •••• | |
Pharmaceuticals and personal care products are contract-manufactured and retailed. | pharmacalway.com | Oak Creek, United States | 1896 | Aug 2024 | •••• | |
Ointments for multiple therapeutic areas are manufactured via R&D focus. | adskinhealth.com | Boca Raton, United States | 2020 | Apr 2023 | •••• | |
Pain relief sprays are manufactured and distributed by Solarcaine. | solarcaine.com | Boca Raton, United States | 1996 | Apr 2023 | •••• | |
Pain-relieving cleansing sprays and first aid sprays are manufactured. | bactine.com | United States | 1950 | Dec 2015 | •••• | |
FDS is recognized for personal care products focused on freshness. | findfds.com | 2018 | Dec 2015 | •••• | ||
Drugs and health supplements are manufactured to control morning sickness. | bonine.com | Sarasota, United States | 1995 | Sep 2014 | •••• |
Complete acquisition details for WellSpring Pharmaceutical
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of WellSpring Pharmaceutical
10 dated milestones of WellSpring Pharmaceutical across 27 years, from founding to its latest funding, stage changes and deals.
- Founded WellSpring Pharmaceutical is founded.
- Acquisition Acquires Bonine.
- Acquisition Acquires FDS.
- Acquisition Acquires Bactine.
- Exit Acquired by Audax Private Equity.
- Exit Acquired by Avista Capital Partners.
- Acquisition Acquires Solarcaine.
- Acquisition Acquires ADskinhealth.
- Acquisition Acquires Wisconsin Pharmacal Company.
- Acquisition Acquires DerMend.
Web traffic of WellSpring Pharmaceutical
The website of WellSpring Pharmaceutical (wellspringpharm.com) receives about 2K visits a month.
- Monthly visits2K
▲ 67.5% vs previous month
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as WellSpring Pharmaceutical (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about WellSpring Pharmaceutical
WellSpring Pharmaceutical was founded in 1999.
WellSpring Pharmaceutical is headquartered in Sarasota, United States. It is registered at Sarasota, Florida, United States.
WellSpring Pharmaceutical has 137 employees.
In Oct 2011, Well Spring Pharma was acquired by the PE firms Sentinel Capital Partners and Ancor Capital Partners. Wellspring is a manufacturer and marketer of prescription and branded OTC health and personal care products for the US and Canadian markets. WellSprings products have widespread distribution through pharmaceutical distributors, wholesalers, and major food and drug retailers. The company has a philosophy of developing and marketing niche products including Gelusil, Emetrol and Micatin. WellSpring owns and operates an FDA and Health Canada approved manufacturing plant in Oakville, Ontario, Canada.
WellSpring Pharmaceutical has made 7 acquisitions, including ADskinhealth, Bactine, and Bonine.
WellSpring Pharmaceutical has 2 investors. Key investors include Avista Capital Partners, and Audax Private Equity.
WellSpring Pharmaceutical operates through Wellspring Pharmaceutical Corporation.
Yes. WellSpring Pharmaceutical was acquired by Avista Capital Partners in August 2022.